No prime time yet for checkpoint inhibitors in localised head and neck squamous cell carcinoma

被引：2
|
作者：
Voortman, Jens [1 ]
机构：
[1] Vrije Univ Amsterdam, Canc Ctr Amsterdam, Dept Med Oncol, Amsterdam UMC, NL-1081 HV Amsterdam, Netherlands
来源：
LANCET ONCOLOGY | 2024年 / 25卷 / 05期
关键词：
RECURRENT;
D O I：
10.1016/S1470-2045(24)00197-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：533 / 534
页数：2
相关论文
共 50 条
  • [41] Changes in the tumor microenvironment in recurrent head and neck squamous cell carcinoma and its implication on efficacy of immune checkpoint inhibitors
    Kim, Dong Hyun
    Kang, Mingu
    Park, Gahee
    Mostafavi, Mohammad
    Lim, Yoojoo
    Ock, Chan-Young
    Koh, Jiwon
    Jeon, Yoon Kyung
    Jung, Kyeong Cheon
    Ahn, Soon-Hyun
    Chung, Eun-Jae
    Kwon, Seong-Keun
    Keam, Bhumsuk
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [42] USING RADIATION THERAPY TO PRIME THE IMMUNE SYSTEM IN HEAD AND NECK SQUAMOUS CELL CARCINOMA
    Calame, D. J.
    Oweida, A.
    Lennon, S.
    Bhatia, S.
    Sharma, J.
    Griego, A.
    Karam, S.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (01) : 142 - 143
  • [43] Spindle assembly checkpoint defects and chromosomal instability in head and neck squamous cell carcinoma
    Minhas, KM
    Singh, B
    Jiang, WW
    Sidransky, D
    Califano, JA
    INTERNATIONAL JOURNAL OF CANCER, 2003, 107 (01) : 46 - 52
  • [44] Obesity and Survival After Immune Checkpoint Inhibition for Head and Neck Squamous Cell Carcinoma
    Mastrolonardo, Eric V.
    Llerena, Pablo
    Lu, Joseph
    Nunes, Kathryn
    Choi, Grace K.
    Amin, Dev
    Bridgham, Kelly M.
    Campbell, Daniel
    Philips, Ramez
    Cognetti, David M.
    Luginbuhl, Adam J.
    Curry, Joseph M.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2024,
  • [45] Gene mutation analysis and immune checkpoint therapy in head and neck squamous cell carcinoma
    Hua Yang
    Yuxue Wei
    Gangli Liu
    Oncology and Translational Medicine, 2022, 8 (01) : 36 - 42
  • [46] Combining Radiation and Immune Checkpoint Blockade in the Treatment of Head and Neck Squamous Cell Carcinoma
    Manukian, Gregor
    Bar-Ad, Voichita
    Lu, Bo
    Argiris, Athanassios
    Johnson, Jennifer M.
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [47] Effectiveness of selected HDAC inhibitors on head and neck squamous cell carcinoma cell lines
    Enzenhofer, E.
    Kadletz, L.
    Stanisz, I.
    Heiduschka, G.
    Kotowski, U.
    Seemann, R.
    Schmid, R.
    Thurnher, D.
    ORAL ONCOLOGY, 2015, 51 (05) : E55 - E55
  • [48] Predictive biomarkers and EGFR inhibitors in squamous cell carcinoma of head and neck (SCCHN)
    Vigneswara, V.
    Kong, A.
    ANNALS OF ONCOLOGY, 2018, 29 (04) : 794 - 796
  • [49] Angiogenesis Inhibitors for Head and Neck Squamous Cell Carcinoma Treatment: Is There Still Hope?
    Hyytiainen, Aini
    Wahbi, Wafa
    Vayrynen, Otto
    Saarilahti, Kauko
    Karihtala, Peeter
    Salo, Tuula
    Al-Samadi, Ahmed
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [50] mTOR Inhibitors and its Role in the Treatment of Head and Neck Squamous Cell Carcinoma
    Shaun A. Nguyen
    David Walker
    M. Boyd Gillespie
    J. Silvio Gutkind
    Terry A. Day
    Current Treatment Options in Oncology, 2012, 13 : 71 - 81
12345